Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are receiving chemotherapy to treat a solid tumour (a type of cancer that forms a lump or growth in the body)
- People who are over 18 years of age
Who may not be able to join:
- People who are 18 years of age or younger
- People who already have nerve damage (neuropathy) before starting the trial
- People who have been diagnosed with a psychiatric (mental health) illness
- People who are already taking medication to treat nerve pain or nerve damage
- People who have had diabetes for more than 10 years
- People who have kidney or liver disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessment of different type and severity of Neuropathy in Solid Cancer Patients Undergoing Chemotherapy using Total Neuropathy Score(TNS) and Nerve conduction velocity study; NOX4 Gene Expression in Blood of Solid Cancer Patients Undergoing Chemotherapy; Serum Vitamin D and Homocysteine Levels in Solid Cancer Patients Undergoing Chemotherapy; serum catalase and malondialdehyde level in solid cancer patients undergoing chemotherapy; Nerve conduction studies (NCS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.